1. Introduction {#sec0005}
===============

Metaplastic breast carcinoma (MBC) is a heterogeneous group of neoplasm which is characterized by a closely related mixture of adenocarcinoma with areas of squamous, spindle, osseous and chondroid differentiation [@bib0005]. MBC is a rare type of breast cancer comprising \<1% of all invasive breast cancers [@bib0010]. Osseous differentiation is a very rare subtype of MBC [@bib0015]. Because of the rarity of the condition, clinical and pathological characteristics are not fully understood [@bib0010]. In line with SCARE guide line, we report a case of MBC with extensive osseous differentiation [@bib0020].

1.1. Patient information {#sec0010}
------------------------

A 48-year-old house wife (post menopausal) presented with painless lump in her left breast of 2 month duration, rapidly grew in size, no significant past medical history, negative family history of breast carcinoma.

1.2. Clinical findings {#sec0015}
----------------------

On clinical examination: A hard mass of about 3 × 3 cm in diameter was noted at 5 o'clock of left breast, the mass well defined and not attached to the skin and chest wall, no skin change was observed, there was no nipple retraction & axillary lymph nodes were not palpable.

1.3. Diagnostic assessment {#sec0020}
--------------------------

Mammography showed relatively well demarcated and calcified mass with speculated margin ([Fig. 1](#fig0005){ref-type="fig"}). Breast ultrasound showed calcified hard mass with back ground shadowing measuring about 3 × 3 cm at 5 o'clock. Fine needle aspiration cytology was positive for malignant cells. Core needle biopsy was performed which confirmed metaplastic breast carcinoma with extensive osseous differentiation. Computed tomography (CT) scan of chest & abdomen revealed densely calcified lesion with lobulated outline of about 37 × 31 millimeters at inferior part of left breast ([Fig. 2](#fig0010){ref-type="fig"}), no distant metastasis was found. Routine hematology and biochemical investigations were within normal limits.

1.4. Therapeutic intervention {#sec0025}
-----------------------------

Simple mastectomy with axillary lymph node sampling was performed, gross description of specimen showed round, very hard mass. Microscopic examination showed MBC with osseous differentiation. Immunohistochemistry analysis confirmed the origin of the histologically metaplastic carcinoma (osteosarcoma pattern) by hormone receptor (ER, PR, Her2) negative & cytokeratin CK 7 & AE1\\AE3 positive. The patient was sent for chemoradiotherapy and on 6 month follow up there was no recurrence of the disease.

2. Discussion {#sec0030}
=============

MBCs are a highly heterogeneous subgroup of tumors recognized as ductal carcinoma with areas of squamous, spindle, chondroid with or without osseous differentiation [@bib0005]. Osseous and chondroid differentiation may occur focally in 0.2% of carcinoma of breast, while osseous metaplasia is the rarest subtype [@bib0015]. Still there is controversy regarding classification of MBC [@bib0010]. Some authors divide the disease is into two main subgroups: (1) homogeneous sarcomatoid/spindle cell carcinoma, and (2) heterogeneous carcinosarcoma associated with sarcomatous differentiation (chondroid, osseous, and rhabdoid) [@bib0025]. Usually adenocarcinomas showing heterologous cartilage or osteoid pattern are presented together, and as a consequence, there is limited specific information on either of them [@bib0005]. The mean age and the clinical characteristics are the same as in other series of MBC [@bib0030]. MBC with osseous differentiation shows macroscopic dense calcifications on mammography as in the current case [@bib0035]. In case of MBC with heterologous pattern, the correlation between survival or recurrence and nodal metastases is not well understood [@bib0005]. Risk factors for developing recurrence in MBC are diffuse cellularity, larger tumor size and atypical metaplasia [@bib0040]. MBC is different from typical adenocarcinomas in several aspects. It less commonly affects lymph nodes with an incidence ranging from 6 to 26% while more commonly develops metastastic disease [@bib0010]. Rate of recurrence for node-negative invasive ductal carcinoma has ranged from 17% to 20% within 2--5 years of diagnosis. This compares with recurrence rate of 35--62% for MBC within the same time period [@bib0045]. The indications of adjuvant chemotherapy and optimal management of MBC (especially osseous differentiation) are uncertain due to the absence of a dependable data [@bib0005]. Bellino and associates advised surgical and adjuvant chemotherapy to be performed according to the recommendations for most other breast carcinomas [@bib0050]. Viewing from this perspective, we sent our patient to chemotherapy.

In conclusion, MBC with osseous differentiation is a very rare type of breast carcinoma presenting with hard mass and managed by mastectomy, axillary lymph node sampling and adjuvant chemotherapy.
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